Partnering With Leading Innovator TrakCel To Support Cell And Gene Therapies

Pipette cell therapy GettyImages-1406383393

Our combined offering aims to increase speed-to-therapy by increasing connectivity between providers and hub patient services.

TrakCel, a leading supplier of cellular orchestration solutions for clinical trials and commercial therapies to the cell and gene therapy industry, partnered with Cencora to launch an integrated technology platform. The platform is designed to accelerate patient access to prescribed cell and gene therapies and deliver complete visibility to physicians and patient services teams across the treatment development and patient journey, enabling seamless care coordination and timely patient engagement.

The enhanced offering combines two platforms—OCELLOS, TrakCel’s advanced therapy orchestration platform, and Fusion, a customer relationship management and patient support ecosystem powered by Cencora. With the integration between OCELLOS and Fusion, we are entering a new phase in therapy ecosystem connectivity.